Contraception is the use of agents, drugs, devices, surgical procedures, for the prevention of unwanted pregnancy. Various Devices, along with treatments, are available for both women and men. The effectiveness of the method depends on how carefully a method has been used. For instance, the use of the contraceptive pill is a 99% efficient method but still 9 women every year become pregnant while using this method. The demand for Contraceptive drugs and devices is increasing on account of the necessity for the prevention of rising rates of unintended pregnancies and increasing consciousness amongst people regarding contraceptive pills. However, some of the restraints in the market include the side effects associated with the use of contraceptive drugs and the high cost of devices and treatments. In 2019, of the 1.9 billion women of reproductive age (15-49 years) living in the world, 1.1 billion needed family planning, they are either current users of contraceptives, 842 million use modern methods of contraception and 80 million use traditional methods or have an unmet need for family planning. 190 million women want to avoid pregnancy and do not use any contraceptive method.
Based on Products, the market is segmented into drugs and devices. The drugs segment is further bifurcated into Oral Contraceptives, Topical Contraceptives and Contraceptive Injectable. The devices segment is bifurcated into Condoms, Diaphragms, Cervical Caps, Sponges Vaginal Rings, and IUD. Within the Contraceptive drugs and device market, oral contraceptives hold the major share due to the following reasons Oral Contraceptive pills are 99% effective for the prevention of pregnancy; hence it is widely used by women; Easy to intake; Easily available as over-the-counter oral contraceptives and Inexpensive. The oral Contraceptives segment generated revenue of USD XX million in 2020. The market is expected to grow at a CAGR of XX% during the forecast period to reach a market valuation of USD XX million by 2027F. In terms of Devices, condoms are mainly used owing to increase cases of unwanted pregnancies, increase cases of STDs, and an increasing government initiative to tackle increasing population.
Based on Gender, the market is divided into Male and Female. The Male subsegment grabbed the major market owing to the increase in commercialization of male birth control Devices such as contraceptive injection for men. The Male sub-segment generated revenue of USD XX million in 2020. The female subsegment grabbed the major market owing to an increase in unwanted pregnancies and government initiatives. The Female sub-segment generated revenue of USD XX million in 2020. Based on the distribution channel, the market is segmented into Hospital & Clinics, Retail Pharmacy, Online Pharmacy, and Others. The retail pharmacy is expected to be the fastest-growing market owing to an increase in over-the-counter purchasing of contraceptive drugs.
For a better understanding of the market adoption, the market is analyzed based on its worldwide adoption in countries such as North America (US, Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, UK, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the Contraceptive Drugs and Devices industry, with revenue share of XX% in 2020. The global Contraceptive Drugs and Devices Market was valued at USD XX million in 2020 and is projected to expand significantly with a CAGR of XX% from 2021F to 2027F. The global Contraceptive Drugs and Devices Market is expected to witness a boost on account of the necessity for the prevention of rising rates of unintended pregnancies and increasing consciousness amongst people regarding contraceptive pills.
Some of the major players operating in the market include Bayer AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Mylan N.V., Allergan Plc, Agile Therapeutics, Piramal Enterprises Ltd., GlaxoSmithKline PLC, Johnson & Johnson, Novartis AG, and Sanofi etc. Several M&A's along with partnerships have been undertaken by these players to boost their presence in different regions.
Contraception is the use of agents, drugs, devices, surgical procedures, for the prevention of unwanted pregnancy. Various devices, along with treatments, are available for both women and men. The effectiveness of the method depends on how carefully a method has been used. For instance, the use of the contraceptive pill is a 99% efficient method but still 9 women every year become pregnant while using this method. The demand for contraceptive drugs and devices is increasing as to avoid the unintended pregnancies and awareness amongst people regarding contraceptive pills. However, some of the restraints in the market include the side effects associated with the use of contraceptive drugs and the high cost of devices and treatments. Contraceptive pills contain the combination of estrogen and progesion in very low-dose (10-30 mcg). Minipills are also used as birth control pill that contains progestin only. In 2019, of the 1.9 billion women of reproductive age (15-49 years) living in the world, 1.1 billion needed family planning, they are either current users of contraceptives, 842 million use modern methods of contraception and 80 million use traditional methods or have an unmet need for family planning. 190 million women want to avoid pregnancy and do not use any contraceptive method.
The main products that are developed for the contraception are Permanent Sterilization, Long-Acting Reversible Contraceptives (LARC), Contraceptive Injection, Short-Acting Hormonal Methods and Barrier Methods. Every woman once in a lifetime uses contraception except if they are seeking pregnancy, postpartum, or sexually inactive. Women mainly prefer having contraception pills. Oral contraceptive pill mainly contains the combination of progestogen and estrogen and is mainly indicated as birth control pill. The benefits associated with the use of contraceptive pills are that the menstrual bleeds become regular and less painful, risk of ovarian cancer, premenstrual syndrome, acne is reduced, and protects against pelvic inflammatory diseases.
Insights Presented in the Report
Based on product type the market is bifurcated into drug and devices.
"Amongst Drugs, Oral Contraceptives segment holds the major market share in 2020"
Based on drugs the global Contraceptive drugs and devices market is bifurcated into Oral Contraceptives, Topical Contraceptives and Contraceptive Injectable. Among all, oral contraceptives segment hold the major share due to the following reasons including 99% effictiveness rate for the prevention of unwanted pregnancy, easy to intake, easily available as over-the-counter oral contraceptives and inexpensive.
"Amongst Devices, Condoms segment holds the major share."
Contraceptive Devices are bifurcated into Condoms, Diaphragms, Cervical Caps, Sponges Vaginal Rings, and IUD. Condoms segment are mainly used among the working age population as a method to prevent unwanted pregnancies, increase cases of STDs, and an increasing government initiatives to reduce population among others.
"Amongst Gender, both Male and Females are anticipated to grow at significant pace"
Based on Gender, the global Contraceptive drugs and devices market is divided into Male and Female. The Male subsegment grabbed the major market owing to the increase in commercialization of male birth control Devices such as contraceptive injection for men. The female subsegment grabbed the major market owing to an increase in unwanted pregnancies and government initiatives.
Amongst Distribution Channel, the Retail Pharmacy holds the major share"
Based on the distribution channel, the global Contraceptive drugs and devices market is segmented into Hospital & Clinics, Retail Pharmacy, Online Pharmacy, and Others. The retail pharmacy is expected to be the fastest-growing market owing to an increase in over-the-counter purchasing of contraceptive drugs.
"North America signifies one of the largest markets of Contraceptive Drugs and Devices Market."
For a better understanding of the market dynamics of the Contraceptive Drugs and Devices market, a detailed analysis was conducted for different regions and countries including North America (US, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, UK and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of APAC), Rest of World. North America dominated the market on the account of lifestyle changes which are the cause of various acute and chronic diseases, and its robust applications in cryosurgery, hypothermia, transplantation, and vaccination. The boost in the Contraceptive Drugs and Devices market is expected due to a rise in demand from several end-use industries and investments in R&D.
Reasons to buy this report:
? The study includes market sizing and forecasting analysis validated by authenticated key industry experts
? The report presents a quick review of overall industry performance at one glance
? The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
? Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
? The study comprehensively covers the market across different segment and sub-segments
? Deep dive regional level analysis of the industry
Customization Options:
Contraceptive Drugs and Devices Market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
Table of Contents
1 MARKET INTRODUCTION
1.1 Market Definitions
1.2 Objective of the Study
1.3 Limitation
1.4 Stake Holders
1.5 Currency Used in Report
1.6 Scope of the Global Contraceptive Drugs and Devices Market Study
2 RESEARCH METHODOLOGY OR ASSUMPTION
2.1 Research Methodology for the Global Contraceptive Drugs and Devices Market
2.1.1 Main Objective of the Global Contraceptive Drugs and Devices Market
3 MARKET SYNOPSIS
4 EXECUTIVE SUMMARY
5 GLOBAL CONTRACEPTIVE DRUGS AND DEVICES MARKET ANALYSIS 2019-27F
6 MARKET INSIGHTS BY PRODUCTS
6.1 By Drugs
6.1.1 Oral Contraceptives
6.1.2 Topical Contraceptives
6.1.3 Contraceptive Injectable
6.2 By Devices
6.2.1 Condoms
6.2.2 Diaphragms
6.2.3 Cervical Caps
6.2.4 Sponges
6.2.5 Vaginal Rings
6.2.6 IUDs
6.2.7 Other Devices
7 MARKET INSIGHTS BY GENDER
7.1 Male
7.2 Female
8 MARKET INSIGHTS BY DISTRIBUTION CHANNEL
8.1 Hospital & Clinics
8.2 Retail Pharmacy
8.3 Online Pharmacy
8.4 Others
9 MARKET INSIGHTS BY REGION
9.1 NORTH AMERICA CONTRACEPTIVE DRUGS AND DEVICES MARKET
9.1.1 United States
9.1.2 Canada
9.1.3 Rest of North America
9.2 EUROPE CONTRACEPTIVE DRUGS AND DEVICES MARKET
9.2.1 Germany
9.2.2 France
9.2.3 United Kingdom
9.2.4 Spain
9.2.5 Italy
9.2.6 Rest of Europe
9.3 ASIA PACIFIC CONTRACEPTIVE DRUGS AND DEVICES MARKET
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 Australia
9.3.5 Rest of Asia Pacific
9.4 REST OF WORLD CONTRACEPTIVE DRUGS AND DEVICES MARKET
10 GLOBAL CONTRACEPTIVE DRUGS AND DEVICES MARKET DYNAMICS
10.1 Drivers
10.2 Challenges
10.3 Impact Analysis
10.4 Market Opportunity
11 CONTRACEPTIVE DRUGS AND DEVICES MARKET TRENDS
12 LEGAL & REGULATORY FRAMEWORK
13 DEMAND AND SUPPLY SIDE ANALYSIS
13.1 Demand Side Analysis
13.2 Supply Side Analysis
13.2.1 Top Product Launches
13.2.2 Top Business Partnerships
13.2.3 Top Business Expansions, Investments and Divestitures
13.2.4 Top Merger and Acquisitions
14 VALUE CHAIN ANALYSIS
15 COMPETITIVE SCENARIO
15.1 Porter's Five Forces Analysis
15.1.1 Bargaining power of Supplier
15.1.2 Bargaining power of Buyer
15.1.3 Industry Rivalry
15.1.4 Availability of Substitute
15.1.5 Threat of new Entrants
15.2 Competitive Landscape
15.2.1 Company Shares, By Revenue
16 COMPANY PROFILED
16.1 Bayer AG
16.2 Pfizer Inc
16.3 Teva Pharmaceutical Industries Ltd
16.4 Merck & Co. Inc.
16.5 Mylan NV
16.6 Allergan Plc.
16.7 Agile Therapeutics
16.8 Piramal Enterprises Ltd
16.9 GlaxoSmithKline PLC
16.10 Johnson & Johnson
16.11 Novartis AG
16.12 Sanofi
17 DISCLAIMER
Bayer AG
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
Merck & Co.
Inc.
Mylan N.V.
Allergan Plc
Agile Therapeutics
Piramal Enterprises Ltd.
GlaxoSmithKline PLC
Johnson & Johnson
Novartis AG
and Sanofi